Cargando…
HDAC8 affects MGMT levels in glioblastoma cell lines via interaction with the proteasome receptor ADRM1
Temozolomide (TMZ) is an alkylating agent chemotherapy drug used as a first-line treatment for glioblastoma multiforme (GBM). O(6)-methyl-guanine DNA methyltransferase (MGMT) repairs DNA damage induced by TMZ; hence, elevated MGMT levels usually correlate with TMZ resistance. MGMT promoter methylati...
Autores principales: | Santos-Barriopedro, Irene, Li, Yixuan, Bahl, Sonali, Seto, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872666/ https://www.ncbi.nlm.nih.gov/pubmed/31798765 http://dx.doi.org/10.18632/genesandcancer.197 |
Ejemplares similares
-
EGFR phosphorylates HDAC1 to regulate its expression and anti-apoptotic function
por: Bahl, Sonali, et al.
Publicado: (2021) -
Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer
por: Fejzo, Marlena S., et al.
Publicado: (2013) -
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma
por: Jiang, Rosie T., et al.
Publicado: (2017) -
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors
por: Anchoori, Ravi K., et al.
Publicado: (2021) -
Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023)